Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Abstract Background Second allogeneic hematopoietic stem cell transplant (HCT) remains as an option for disease relapse after initial HCT. Methods We analyzed retrospectively the outcomes of 65 consecutive patients who underwent a second HCT for disease relapse at the University of Chicago. Univaria...

Full description

Bibliographic Details
Main Authors: Yun Fan, Andrew S. Artz, Koen van Besien, Wendy Stock, Richard A. Larson, Olatoyosi Odenike, Lucy A. Godley, Justin Kline, John M. Cunningham, James L. LaBelle, Michael R. Bishop, Hongtao Liu
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Experimental Hematology & Oncology
Subjects:
Second allogeneic bone marrow transplantation
T cell depletion
Non-relapse mortality
Online Access:http://link.springer.com/article/10.1186/s40164-018-0125-6

Internet

http://link.springer.com/article/10.1186/s40164-018-0125-6

Similar Items